Cellebrite DI Ltd.

NasdaqGS:CLBT Stock Report

Market Cap: US$4.9b

Cellebrite DI Future Growth

Future criteria checks 5/6

Cellebrite DI is forecast to grow earnings and revenue by 87.2% and 14% per annum respectively. EPS is expected to grow by 116.2% per annum. Return on equity is forecast to be 20.9% in 3 years.

Key information

87.2%

Earnings growth rate

116.2%

EPS growth rate

Software earnings growth17.0%
Revenue growth rate14.0%
Future return on equity20.9%
Analyst coverage

Good

Last updated16 Dec 2024

Recent future growth updates

Recent updates

Cellebrite: There Are Potential Risks That Could Damper Growth

Nov 08

Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?

Oct 30
Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?

There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Sep 10
There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Cellebrite: Rating Downgrade As Valuation Has Caught Up

Aug 27

Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Aug 17
Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Jun 25
Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

May 21
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

Cellebrite: Big Fish In A Small Pond

Apr 29

Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Mar 14
Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

Feb 18
Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Jan 28
There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Earnings and Revenue Growth Forecasts

NasdaqGS:CLBT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026553841741816
12/31/2025466651391498
12/31/2024399-2931131218
9/30/2024385-31799110N/A
6/30/2024362-1038798N/A
3/31/2024343-11291100N/A
12/31/2023325-8194102N/A
9/30/2023306-648894N/A
6/30/2023294-425764N/A
3/31/2023280203644N/A
12/31/20222711161121N/A
9/30/2022265165815N/A
6/30/202225915217N/A
3/31/20222551221726N/A
12/31/2021246702836N/A
9/30/202123673038N/A
6/30/202122375563N/A
3/31/202120926672N/A
12/31/2020195-96067N/A
12/31/2019172-101016N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLBT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: CLBT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: CLBT is expected to become profitable in the next 3 years.

Revenue vs Market: CLBT's revenue (14% per year) is forecast to grow faster than the US market (9.1% per year).

High Growth Revenue: CLBT's revenue (14% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CLBT's Return on Equity is forecast to be high in 3 years time (20.9%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 10:27
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cellebrite DI Ltd. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tal LianiBofA Global Research
Tomer ZilbermanBofA Global Research
Tyler RadkeCitigroup Inc